News | Cardiac Imaging | August 04, 2015

Specific Cardiovascular Risk Factors May Predict Alzheimer’s Disease

MRI-based study connects alcohol consumption, smoking, obesity and diabetes with gray matter volume reduction in different areas of the brain

MRI, cardiovascular risk factors, Alzheimer's disease, early predictors

August 4, 2015 — Specific cardiovascular risk factors are associated with smaller regional brain volumes that may be early indicators of Alzheimer’s disease and dementia, according to a study published online in the journal Radiology. Those factors include alcohol consumption, smoking, obesity and diabetes.

“We already know that vascular risk factors damage the brain and can result in cognitive impairment,” said Kevin S. King, M.D., assistant professor of radiology at the Keck School of Medicine of the University of Southern California in Los Angeles. “But our findings give us a more concrete idea about the relationship between specific vascular risk factors and brain health.”

Prior studies have linked cardiovascular risk factors and cognitive decline, but the new study focused on specific risk factors and examined three main brain regions, including the hippocampus, precuneus and posterior cingulate cortex. Because of each region’s connection to memory retrieval, gray matter volume loss in these areas may be a predictor of Alzheimer’s disease and dementia.

In the new study, King and colleagues analyzed results from 1,629 individuals in the Dallas Heart Study (DHS) and divided the participants into two age groups. There were 805 participants under age 50, and 824 age 50 and older. The researchers evaluated the participants’ data from the initial baseline visit, which included laboratory and clinical analysis, and the follow-up visit seven years later consisting of a brain magnetic resonance imaging (MRI) scan and cognitive test, measuring mild cognitive impairment and preclinical Alzheimer’s disease.

By comparing the initial visit, which identified cardiovascular risk factors, to the MRI results and cognitive scores, the team distinguished the specific risk factors of alcohol consumption, smoking, diabetes and obesity and their relationship to smaller volumes in the three targeted regions of the brain. The results confirmed that lower cognitive test scores correlated with lower brain volumes in each area.

The study found alcohol use and diabetes were associated with smaller total brain volume, while smoking and obesity were linked with reduced volumes of the posterior cingulate cortex (the area of the brain connected with memory retrieval as well as emotional and social behavior). In addition, lower hippocampal mass was linked to both alcohol consumption and smoking, whereas alcohol use, obesity and high fasting blood glucose numbers correlated with reduced precuneus size.

The findings also suggest that diminished hippocampal and precuneus volumes may be early risk indicators for cognitive decline in patients age 50 and older, while smaller posterior cingulate volumes are better predictors in patients under 50.

King believes that additional studies could better identify the impact of specific cardiovascular risk factors on the brain and improve patient understanding of brain diseases.

“We currently do not have effective treatments for Alzheimer’s disease, so the focus is on prevention,” he said. “In the future, we may be able to provide patients with useful and actionable information about the impact different risk factors may be having on their brain health during routine clinical imaging. And since no special imaging equipment is needed, there is a great potential to provide this service at many centers across the country.” 

For more information: www.radiologyinfo.org

Related Content

Medtronic Announces Global Resolute Onyx DES One-Month DAPT Study
News | Antiplatelet and Anticoagulation Therapies| August 18, 2017
Medtronic plc announced a global randomized clinical trial that will evaluate one-month dual antiplatelet therapy (DAPT...
ASNC and SNMMI Release Joint Document on Diagnosis, Treatment of Cardiac Sarcoidosis
News | Cardiac Imaging| August 18, 2017
August 18, 2017 — The American Society of...
Houston Methodist Hospital Enters Multi-Year Technology and Research Agreement With Siemens Healthineers
News | Cardiac Imaging| August 17, 2017
Houston Methodist Hospital and Siemens Healthineers have entered into a multi-year agreement to bring cutting-edge...
Bivalirudin exhibited an improvement in 30-day all-cause mortality when injected post PCI.
News | Antiplatelet and Anticoagulation Therapies| August 16, 2017
August 16, 2017 — A study has examined the efficacies of various post-percutaneous coronary intervention (PCI) bivali
ESC 2017 late breaking trial hot line study presentations.
News | Clinical Study| August 16, 2017
Aug. 16, 2017 – The European Society of Cardiology (ESC) Congress 2017 includes several Hot Line Late-breaking Clinic
ISMRM Issues Guidelines for MRI Gadolinium Contrast Agents
News | Magnetic Resonance Imaging (MRI)| August 15, 2017
The International Society for Magnetic Resonance in Medicine (ISMRM) has provided new guidance in the use of contrast...
News | Drug-Eluting Balloons| August 15, 2017
Surmodics Inc. announced receipt of an investigational device exemption (IDE) from the U.S. Food and Drug...
The Vascular Dynamics MobiusHD device enhances the carotid baroreceptors to reduce resistant hypertension.
News | Hypertension| August 15, 2017
Aug. 15, 2017 — The U.S. Food and Drug Administration (FDA) has approved the Vascular Dynamics Inc.
Overlay Init